research papers crystal structure analysis of icosahedral...

9
research papers Acta Cryst. (2011). D67 doi:10.1107/S0907444910053370 1 of 9 Acta Crystallographica Section D Biological Crystallography ISSN 0907-4449 Crystal structure analysis of icosahedral lumazine synthase from Salmonella typhimurium, an antibacterial drug target Pankaj Kumar, Mirage Singh and Subramanian Karthikeyan* Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39-A, Chandigarh 160 036, India Correspondence e-mail: [email protected], [email protected] # 2011 International Union of Crystallography Printed in Singapore – all rights reserved Riboflavin biosynthesis is an essential pathway in bacteria, in contrast to animals, which obtain riboflavin from their diet. Therefore, the enzymes involved in the riboflavin-biosynthesis pathway are potential targets for the development of anti- bacterial drugs. Lumazine synthase, an enzyme that is involved in the penultimate step of riboflavin biosynthesis, catalyzes the formation of 6,7-dimethyl-8-ribityllumazine from 3,4- dihydroxy-2-butanone 4-phosphate and 5-amino-6-ribityl- amino-2,4-(1H,3H)-pyrimidinedione. Lumazine synthase from Salmonella typhimurium (sLS) has been cloned, over- expressed and purified and was crystallized in three forms, each with different crystal packing. The crystal structure of sLS in the monoclinic space group P2 1 has been determined with 60 subunits per asymmetric unit, packed as an icosahedron, at 3.57 A ˚ resolution. Interestingly, sLS contains an N-terminal proline residue (Pro11) which had previously been suggested to disrupt the formation of the icosohedral assembly. In addition, comparison of the structure of sLS with known orthologous lumazine synthase structures allowed identification of the amino-acid residues involved in substrate binding and catalysis. The sLS structure reported here could serve as a starting point for the development of species- specific antibacterial drugs. Received 12 August 2010 Accepted 20 December 2010 PDB Reference: lumazine synthase, 3mk3. 1. Introduction Riboflavin (vitamin B 2 ) is biosynthesized in bacteria, fungi and plants, but animals are dependent on nutritional resources for this vitamin (Young, 1986; Bacher, 1991). Flavin mono- nucleotide (FMN) and flavin adenine dinucleotide (FAD), which are derivatives of riboflavin, are essential cofactors in living cells as they play important roles in many redox reac- tions, including amino-acid metabolism, DNA repair, light sensing and bioluminescence etc. (Meighen, 1991, 1993; O’Kane & Prasher, 1992; Briggs & Huala, 1999; Salomon et al., 2001; Thompson & Sancar, 2002). Gram-negative bacteria such as Escherichia coli and Salmonella sp. are absolutely dependent on the endogenous synthesis of riboflavin (Bacher et al., 1996). Therefore, the enzymes involved in the riboflavin- biosynthesis pathway can be considered to be potential anti- bacterial drug targets. Lumazine synthase (LS) is involved in the penultimate step of the riboflavin-biosynthesis pathway and catalyses the con- densation of 3,4-dihydroxy-2-butanone-4-phosphate (DHBP) and 5-amino-6-ribitylamino-2,4-(1H,3H)-pyrimidinedione (ARAPD) to 6,7-dimethyl-8-ribityllumazine (DMRL; Fig. 1; Volk & Bacher, 1991). The dismutation reaction of two Files: d/xb5025/xb5025.3d d/xb5025/xb5025.sgml XB5025 FA IU-1113/23(3)1 1113/16(3)1 () XB5025 PROOFS D:FA:2011:67:1:0:0–0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114

Upload: others

Post on 04-Aug-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: research papers Crystal structure analysis of icosahedral ...crdd.osdd.net/open/482/1/karthi-acta-d.pdfmixing 1 ml protein solution with 1 ml reservoir buffer, equilibrating against

research papers

Acta Cryst. (2011). D67 doi:10.1107/S0907444910053370 1 of 9

Acta Crystallographica Section D

BiologicalCrystallography

ISSN 0907-4449

Crystal structure analysis of icosahedral lumazinesynthase from Salmonella typhimurium, anantibacterial drug target

Pankaj Kumar, Mirage Singh and

Subramanian Karthikeyan*

Institute of Microbial Technology, Council of

Scientific and Industrial Research (CSIR),

Sector 39-A, Chandigarh 160 036, India

Correspondence e-mail:

[email protected], [email protected]

# 2011 International Union of Crystallography

Printed in Singapore – all rights reserved

Riboflavin biosynthesis is an essential pathway in bacteria, in

contrast to animals, which obtain riboflavin from their diet.

Therefore, the enzymes involved in the riboflavin-biosynthesis

pathway are potential targets for the development of anti-

bacterial drugs. Lumazine synthase, an enzyme that is involved

in the penultimate step of riboflavin biosynthesis, catalyzes

the formation of 6,7-dimethyl-8-ribityllumazine from 3,4-

dihydroxy-2-butanone 4-phosphate and 5-amino-6-ribityl-

amino-2,4-(1H,3H)-pyrimidinedione. Lumazine synthase from

Salmonella typhimurium (sLS) has been cloned, over-

expressed and purified and was crystallized in three forms,

each with different crystal packing. The crystal structure of

sLS in the monoclinic space group P21 has been determined

with 60 subunits per asymmetric unit, packed as an

icosahedron, at 3.57 A resolution. Interestingly, sLS contains

an N-terminal proline residue (Pro11) which had previously

been suggested to disrupt the formation of the icosohedral

assembly. In addition, comparison of the structure of sLS with

known orthologous lumazine synthase structures allowed

identification of the amino-acid residues involved in substrate

binding and catalysis. The sLS structure reported here could

serve as a starting point for the development of species-

specific antibacterial drugs.

Received 12 August 2010

Accepted 20 December 2010

PDB Reference: lumazine

synthase, 3mk3.

1. Introduction

Riboflavin (vitamin B2) is biosynthesized in bacteria, fungi

and plants, but animals are dependent on nutritional resources

for this vitamin (Young, 1986; Bacher, 1991). Flavin mono-

nucleotide (FMN) and flavin adenine dinucleotide (FAD),

which are derivatives of riboflavin, are essential cofactors in

living cells as they play important roles in many redox reac-

tions, including amino-acid metabolism, DNA repair, light

sensing and bioluminescence etc. (Meighen, 1991, 1993;

O’Kane & Prasher, 1992; Briggs & Huala, 1999; Salomon et al.,

2001; Thompson & Sancar, 2002). Gram-negative bacteria

such as Escherichia coli and Salmonella sp. are absolutely

dependent on the endogenous synthesis of riboflavin (Bacher

et al., 1996). Therefore, the enzymes involved in the riboflavin-

biosynthesis pathway can be considered to be potential anti-

bacterial drug targets.

Lumazine synthase (LS) is involved in the penultimate step

of the riboflavin-biosynthesis pathway and catalyses the con-

densation of 3,4-dihydroxy-2-butanone-4-phosphate (DHBP)

and 5-amino-6-ribitylamino-2,4-(1H,3H)-pyrimidinedione

(ARAPD) to 6,7-dimethyl-8-ribityllumazine (DMRL; Fig. 1;

Volk & Bacher, 1991). The dismutation reaction of two

Files: d/xb5025/xb5025.3d d/xb5025/xb5025.sgml XB5025 FA IU-1113/23(3)1 1113/16(3)1 () XB5025 PROOFS D:FA:2011:67:1:0:0–0

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

39

40

41

42

43

44

45

46

47

48

49

50

51

52

53

54

55

56

57

58

59

60

61

62

63

64

65

66

67

68

69

70

71

72

73

74

75

76

77

78

79

80

81

82

83

84

85

86

87

88

89

90

91

92

93

94

95

96

97

98

99

100

101

102

103

104

105

106

107

108

109

110

111

112

113

114

Page 2: research papers Crystal structure analysis of icosahedral ...crdd.osdd.net/open/482/1/karthi-acta-d.pdfmixing 1 ml protein solution with 1 ml reservoir buffer, equilibrating against

molecules of DMRL results in one molecule of riboflavin

and one molecule of ARAPD and is catalyzed by riboflavin

synthase (RS; Plaut et al., 1970; Plaut & Harvey, 1971). The

ARAPD formed in the second half of the reaction is reutilized

by lumazine synthase as a substrate. A proposed mechanism

based on the experimentally observed regiochemistry of

catalysis suggests that the reaction starts with substrate

binding, followed by formation of the Schiff-base intermediate

and elimination of phosphate with subsequent ring closure

that results in the formation of DMRL (Kis et al., 1995).

Mutational and solution studies suggest that the catalytic

function of the enzyme is tightly correlated with its quaternary

structure (Zhang et al., 2006).

LS is very diverse in terms of its structural assembly both in

crystal structures and in solution; it shows a pentameric form

in Magnaporthe grisea (Persson et al., 1999), Saccharomyces

cerevisiae (Meining et al., 2000), Schizosaccharomyces pombe

(Gerhardt et al., 2002), Mycobacterium tuberculosis (Morgu-

nova et al., 2005) and Candida albicans (Morgunova et al.,

2007), dimers of pentamers in Brucella abortus (Zylberman et

al., 2004) and icosahedral capsids consisting of 60 subunits (12

pentamers) in Bacillus subtilis (Ladenstein et al., 1994), E. coli

(Mortl et al., 1996), Spinacia oleracea (Persson et al., 1999) and

Aquifex aeolicus (Zhang et al., 2001). However, comparison of

the three-dimensional structures of LS from different species

reveals a common flavodoxin-like fold regardless of the

quaternary structure of the enzyme.

The folding pattern of LS comprises a

central four-stranded �-sheet flanked by

two �-helices on one side and three on

the other.

A comprehensive study has been

carried out in order to understand the

subunit assembly of lumazine synthases

from different organisms (Persson et al.,

1999). Structural analysis of LS from a

fungal (Ma. grisea) source forming a

pentameric assembly and from a plant

(Sp. oleracea) source forming an icosa-

hedral assembly identified two potential

structural determinants that may con-

tribute to the formation of an icosahe-

dral assembly (Persson et al., 1999).

Firstly, the presence of a proline residue

in the N-terminal region would cause a

distorted conformation that may hinder

formation of the icosahedral assembly.

Secondly, a five-residue loop connecting

the last two C-terminal �-helices (�4

and �5) may play a role in formation of

the icosahedral assembly. In addition, a

systematic sequence analysis of luma-

zine synthases that form pentamers and

icosahedral assemblies identified eight

sequence sites that appear to be deter-

minants of icosahedral assembly

formation (Fornasari et al., 2004). In

spite of these studies, the driving force

and structural elements that are responsible for the formation

of pentamers and icosahedra still remain unclear (Morgunova

et al., 2007). In the current study, we have cloned, expressed,

purified and crystallized the lumazine synthase from Salmo-

nella typhimurium in order to understand its structure–

function relationship, which could be helpful in rational drug

design against this pathogen.

2. Materials and methods

2.1. Cloning, expression and purification of lumazinesynthase

The ribH gene encoding lumazine synthase was amplified

by polymerase chain reaction (PCR) from the genomic DNA

of S. typhimurium using forward 50-TGA TAT ACA CAT ATG

AAC ATT ATT AAA GCT-30 and reverse 50-TTA TAA TCA

CTC GAG TCA GGC CTT AAT TGC-30 primers (IDT,

USA). The amplified PCR product was digested with NdeI

and XhoI restriction enzymes (New England Labs, USA) and

ligated into pET28c vector (Novagen, USA). The integrity of

the ribH gene in the vector was confirmed by DNA sequen-

cing. The resulting plasmid (sLS-pET28c) expresses lumazine

synthase with an N-terminal 6�His tag to enable protein

purification by affinity chromatography. The clone sLS-

research papers

2 of 9 Kumar et al. � Lumazine synthase Acta Cryst. (2011). D67

Figure 1Chemical reaction catalyzed by lumazine synthase. sLS catalyzes the formation of 6,7-dimethyl-8-ribityllumazine (DMRL) using 3,4-dihydroxy-2-butanone 4-phosphate (DHBP) and 5-amino-6-ribitylamino-2,4-(1H,3H)-pyrimidinedione (ARAPD) as substrates.

Files: d/xb5025/xb5025.3d d/xb5025/xb5025.sgml XB5025 FA IU-1113/23(3)1 1113/16(3)1 () XB5025 PROOFS D:FA:2011:67:1:0:0–0

115

116

117

118

119

120

121

122

123

124

125

126

127

128

129

130

131

132

133

134

135

136

137

138

139

140

141

142

143

144

145

146

147

148

149

150

151

152

153

154

155

156

157

158

159

160

161

162

163

164

165

166

167

168

169

170

171

172

173

174

175

176

177

178

179

180

181

182

183

184

185

186

187

188

189

190

191

192

193

194

195

196

197

198

199

200

201

202

203

204

205

206

207

208

209

210

211

212

213

214

215

216

217

218

219

220

221

222

223

224

225

226

227

228

Page 3: research papers Crystal structure analysis of icosahedral ...crdd.osdd.net/open/482/1/karthi-acta-d.pdfmixing 1 ml protein solution with 1 ml reservoir buffer, equilibrating against

pET28c was transformed into E. coli BL21 (DE3) strain for

expression of lumazine synthase. An overnight culture (10 ml)

of single transformant was inoculated into 1 l fresh Luria–

Bertani (LB) medium containing kanamycin (30 mg ml�1) and

was allowed to grow further at 303 K until the absorbance at

600 nm reached a value of about 0.8–1.0. At this stage, ribH

gene expression was induced by adding isopropyl �-d-1-thio-

galactopyranoside (IPTG) to a final concentration of 0.5 mM

and the cells were allowed to grow at 303 K for a further

1 h. The cells were harvested by centrifuging the culture at

5000 rev min�1 for 15 min at 277 K. The supernatant was

discarded and the cell pellet was stored at 193 K until further

processing. The cell pellet was resuspended in 25 ml buffer A

(50 mM Tris pH 8.0, 150 mM NaCl, 1 mM imidazole) followed

by the addition of a cocktail of protease inhibitors (Roche,

USA). The resuspended cells were lysed by sonication for

20 min with 30 s pulses at 277 K (Sonics, USA). The cell debris

was removed by centrifugation at 14 000g for 60 min at 277 K

and the supernatant was passed through a nickel–nitrilo-

triacetic acid (Ni–NTA) column (Qiagen, Germany) pre-

equilibrated with buffer B (50 mM Tris pH 8.0, 150 mM NaCl).

The unbound proteins were washed with 25 column volumes

of buffer C (50 mM Tris pH 8.0, 150 mM NaCl, 20 mM

imidazole) and the bound protein was eluted using buffer D

(50 mM Tris pH 8.0, 150 mM NaCl, 300 mM imidazole). The

eluted protein was subsequently dialyzed against buffer B and

concentrated to 8 mg ml�1 as measured by the Bradford

method (Bradford, 1976) using an

Amicon concentrator (10 kDa cutoff,

Millipore, USA). The purity of the

enzyme was checked by 15% SDS–

PAGE (Laemmli, 1970).

2.2. Crystallization

Purified recombinant sLS (8 mg ml�1

concentration) in 50 mM Tris pH 8.0,

150 mM NaCl was used for crystal-

lization by the sitting-drop vapour-

diffusion method in a 96-well plate

(MRC plates, Molecular Dimensions,

UK). Initially, a screening kit from Jena

Bioscience (Germany) was used to

screen for crystallization conditions by

mixing 1 ml protein solution with 1 ml

reservoir buffer, equilibrating against

60 ml precipitant solution and incu-

bating at 293 K. Plate-like crystals

appeared after 2 d in 1.6 M ammonium

sulfate, 0.1 M Tris pH 8.0. To improve

the crystal quality, the initial condition

was expanded by the hanging-drop

method using a 24-well plate with a 4 ml

drop consisting of 2 ml protein solution

and 2 ml reservoir buffer, which was

equilibrated against 500 ml precipitant

solution and incubated at 293 K. Three

types of crystals were obtained when

the reservoir buffer consisted of 1.6 M

ammonium sulfate, 0.1 M Tris buffer with slightly different

pH values. At pH 7.75 plate-like crystals (crystal form A)

appeared after 3 d. At pH 8.0 tetragonal crystals (crystal form

B) appeared after two months. At pH 8.5 pyramidal crystals

(crystal form C) appeared after two months.

2.3. Data collection and processing

X-ray diffraction data sets for all three crystal forms (A, B

and C) were collected on a MAR345dtb image-plate detector

mounted on a Rigaku MicroMax-007 HF microfocus rotating-

anode X-ray generator operated at 40 kV and 30 mA. All data

sets were collected at 100 K using an Oxford cryostream. Prior

to diffraction, crystals were soaked in a cryoprotectant solu-

tion consisting of 30% glycerol with the respective compo-

nents of the precipitating buffer. For crystal form A, X-ray

diffraction data were collected to 3.50 A resolution as a total

of 67 frames each with 1� oscillation. For crystal form B, a

complete data set extending to 3.57 A resolution was collected

as a total of 71 frames each with 1� oscillation. For crystal form

C, a complete data set extending to 4.11 A resolution was

collected as a total of 139 frames each with 1� oscillation. The

diffraction images for all the data sets were integrated and

scaled using the HKL-2000 suite of programs (Otwinowski &

Minor, 1997). As the data for crystal form B were more

complete and of better quality than those for the A and C

research papers

Acta Cryst. (2011). D67 Kumar et al. � Lumazine synthase 3 of 9

Table 1Data-collection and refinement statistics for S. typhimurium lumazine synthase.

Values in parentheses are for the highest resolution shell.

Crystal form A Crystal form B Crystal form C

Data collectionWavelength (A) 1.542 1.542 1.542Resolution (A) 50.0–3.57 (3.64–3.57) 87.1–3.50 (3.70–3.50) 77.83–4.11 (4.33–4.11)Space group P21 I2 I222Molecules per asymmetric unit 60 30 15Unit-cell parameters (A, �) a = 154.23, b = 151.50,

c = 235.03,� = � = 90,� = 97.08

a = 174.43, b = 157.49,c = 202.79,� = � = 90,� = 91.58

a = 153.0, b = 155.66,c = 213.82,� = � = � = 90

Unique reflections 105485 45638 18225Multiplicity 1.7 (1.6) 2.2 (2.0) 4.1 (3.1)Completeness (%) 83.2 (80.8) 66.5 (70.2) 90.2 (70.5)Rmerge† (%) 9.1 (55.7) 25.8 (39.2) 11.9 (48.6)hI/�(I)i 9.4 (2.0) 3.2 (2.2) 7.1 (2.0)VM (A3 Da�1) 2.6 2.9 2.8Solvent content (%) 52.5 57.6 56.5

RefinementResolution range (A) 32.03–3.57Rcryst‡ (%) 22.6Rfree§ (%) 26.4R.m.s.d. from ideality

Bonds (A) 0.009Angles (�) 0.983

Average B factor, protein (A2) 87.6Ramachandran plot (%)

Most favoured 89.3Additionally allowed 9.9Generously allowed 0.8

† Rmerge =P

hkl

Pi jIiðhklÞ � hIðhklÞij=Phkl

Pi IiðhklÞ. ‡ Rcryst =

Phkl

��jFobsj � jFcalcj

��=P

hkl jFobsj. § Rfree is thecross-validation R factor computed for the test set, which consisted of 1% of the reflections that were not used inrefinement.

Files: d/xb5025/xb5025.3d d/xb5025/xb5025.sgml XB5025 FA IU-1113/23(3)1 1113/16(3)1 () XB5025 PROOFS D:FA:2011:67:1:0:0–0

229

230

231

232

233

234

235

236

237

238

239

240

241

242

243

244

245

246

247

248

249

250

251

252

253

254

255

256

257

258

259

260

261

262

263

264

265

266

267

268

269

270

271

272

273

274

275

276

277

278

279

280

281

282

283

284

285

286

287

288

289

290

291

292

293

294

295

296

297

298

299

300

301

302

303

304

305

306

307

308

309

310

311

312

313

314

315

316

317

318

319

320

321

322

323

324

325

326

327

328

329

330

331

332

333

334

335

336

337

338

339

340

341

342

Page 4: research papers Crystal structure analysis of icosahedral ...crdd.osdd.net/open/482/1/karthi-acta-d.pdfmixing 1 ml protein solution with 1 ml reservoir buffer, equilibrating against

forms, structural analysis was only carried out using the data

obtained from crystal form B. The data-collection statistics for

all of the data sets are given in Table 1.

2.4. Structure determination and refinement

The structure of sLS (crystal form B) was solved by the

molecular-replacement method using Phaser (McCoy et al.,

2005) with lumazine synthase from B. subtilis (Ritsert et al.,

1995) with 30 subunits as a search model (PDB entry 1rvv;

52% sequence identity with sLS). The final solution from

Phaser yielded two ensembles with 30 subunits each, corre-

sponding to 60 subunits in the asymmetric unit. The initial

model was refined by rigid-body refinement using REFMAC5

(Murshudov et al., 1997) as implemented in the CCP4 suite

(Collaborative Computational Project, Number 4, 1994). The

model was further refined using PHENIX (Adams et al., 2010)

by applying 60-fold strict noncrystallographic symmetry

(NCS). The sLS model was built using the program Coot

(Emsley & Cowtan, 2004) and refined iteratively until the

model was completely built. The final model was validated

using the program PROCHECK (Laskowski et al., 1993) from

the CCP4 suite.

3. Results and discussion

3.1. Cloning, expression and purification of lumazinesynthase from S. typhimurium

The ribH gene encoding lumazine synthase from S. typhi-

murium was amplified by polymerase chain reaction, cloned

into the pET28c vector and expressed in E. coli. The recom-

binant protein was purified to homogeneity using 6�His-tag

and Ni–NTA affinity chromatography. The ribH gene encodes

a 156-amino-acid protein with a calculated mass of 16 008 Da.

The molecular mass of purified sLS, including 20 extra amino

acids contributed from the cloning vector, was estimated as

17–18 kDa by SDS–PAGE and 18 100 Da by MALDI analysis.

3.2. Crystal structure determination, refinement and qualityof the model

Lumazine synthase from S. typhimurium was crystallized in

the monoclinic space group P21, with unit-cell parameters

research papers

4 of 9 Kumar et al. � Lumazine synthase Acta Cryst. (2011). D67

Figure 2Stereoview showing the final 2Fo � Fc electron-density map contoured at the 1.0� level (a) for residue Pro11, (b) for the loop connecting the twoC-terminal helices �4 and �5 (the side chains are removed for clarity), (c) for the loop region covering residues 67–76 and (d) for the sulfate ion

Files: d/xb5025/xb5025.3d d/xb5025/xb5025.sgml XB5025 FA IU-1113/23(3)1 1113/16(3)1 () XB5025 PROOFS D:FA:2011:67:1:0:0–0

343

344

345

346

347

348

349

350

351

352

353

354

355

356

357

358

359

360

361

362

363

364

365

366

367

368

369

370

371

372

373

374

375

376

377

378

379

380

381

382

383

384

385

386

387

388

389

390

391

392

393

394

395

396

397

398

399

400

401

402

403

404

405

406

407

408

409

410

411

412

413

414

415

416

417

418

419

420

421

422

423

424

425

426

427

428

429

430

431

432

433

434

435

436

437

438

439

440

441

442

443

444

445

446

447

448

449

450

451

452

453

454

455

456

Page 5: research papers Crystal structure analysis of icosahedral ...crdd.osdd.net/open/482/1/karthi-acta-d.pdfmixing 1 ml protein solution with 1 ml reservoir buffer, equilibrating against

a = 154.23, b = 151.50, c = 235.03 A, � = 97.08�, and data were

collected to 3.57 A resolution. Assuming the molecular weight

of sLS to be about 16 kDa and that there are 60 monomers per

asymmetric unit, the calculated Matthews coefficient corre-

sponds to 2.84 A3 Da�1, with a solvent content of 56.7%,

which is within the normal limits for protein crystals

(Matthews, 1968). The structure of sLS was solved by the

molecular-replacement method using B. subtilis LS as a search

model, which shows 52% sequence identity to sLS. The 30

subunits of LS from B. subtilis were considered as one single

ensemble and Phaser yielded a solution with two ensembles,

giving a total of 60 subunits per asymmetric unit. The 60

subunits were initially refined by rigid-body refinement using

REFMAC5 as implemented in CCP4. The structure together

with the 2Fo � Fc map was displayed in Coot and the first

subunit of the model was manually mutated according to the

S. typhimurium sequence. The complete 60-subunit structure

corresponding to the S. typhimurium sequence was generated

using LSQMAN (Kleywegt & Jones, 1994) by superposing the

first monomer onto the remaining 59 subunits. From this point

research papers

Acta Cryst. (2011). D67 Kumar et al. � Lumazine synthase 5 of 9

Figure 3(a) Cartoon representation of the subunit fold of sLS with secondary-structure elements labelled. (b) Pentamer assembly of sLS; each subunit isrepresented in a different colour. The active site is indicated by the bound sulfate ion, which is shown as spheres. (c) Surface representation of theicosahedral assembly of sLS, showing each pentamer in a different colour. (d) Cross-section of the icosahedral assembly of sLS, showing the dimensionsof each region.

Files: d/xb5025/xb5025.3d d/xb5025/xb5025.sgml XB5025 FA IU-1113/23(3)1 1113/16(3)1 () XB5025 PROOFS D:FA:2011:67:1:0:0–0

457

458

459

460

461

462

463

464

465

466

467

468

469

470

471

472

473

474

475

476

477

478

479

480

481

482

483

484

485

486

487

488

489

490

491

492

493

494

495

496

497

498

499

500

501

502

503

504

505

506

507

508

509

510

511

512

513

514

515

516

517

518

519

520

521

522

523

524

525

526

527

528

529

530

531

532

533

534

535

536

537

538

539

540

541

542

543

544

545

546

547

548

549

550

551

552

553

554

555

556

557

558

559

560

561

562

563

564

565

566

567

568

569

570

Page 6: research papers Crystal structure analysis of icosahedral ...crdd.osdd.net/open/482/1/karthi-acta-d.pdfmixing 1 ml protein solution with 1 ml reservoir buffer, equilibrating against

onwards, the structure was refined using PHENIX by applying

60-fold strict NCS. The NCS-averaged map was calculated and

displayed in Coot for model building.

The sLS structure was refined at 3.57 A resolution to an R

value of 22.6% and a free R value of 26.4%. Each subunit

consisted of 154 amino-acid residues covering the ribH

sequence of S. typhimurium. The quality of the final 60-fold

averaged electron-density map is generally good and the

complete polypeptide chain could be traced in the electron-

density map (Fig. 2). A few residues located on the surface of

the protein had poor electron density, which is expected at this

resolution. In addition, owing to a lack of electron density the

residues from the cloning vector at the N-terminal region and

the last two residues at the C-terminus of sLS were not

included in the model. The difference Fourier map at 3.0�clearly showed extra electron density which could be modelled

as a sulfate ion at the interface of two subunits. The final

model consisted of 9240 residues and 79 sulfate ions (including

ten sulfate ions bound nonspecifically to some chains). The

Ramachandran plot (Ramachandran & Sasisekharan, 1968)

analysis for a monomer in the final model shows that 89.3% of

the residues are in the most favoured region, 9.9% are in the

additionally allowed region and 0.8% are in the generously

allowed region. The refinement statistics are shown in Table 1.

3.3. Overall subunit structure of lumazine synthase

The crystal structure of the sLS monomer consists of 154

residues forming a single domain belonging to the flavodoxin-

like fold, similar to those observed in the icosahedral LS of

B. subtilis, spinach and A. aeolicus (Ritsert et al., 1995; Persson

et al., 1999; Zhang et al., 2001). The core of the sLS has �/�/�topology with four parallel �-strands arranged in the order

�3-�2-�4-�5 forming a central �-sheet surrounded by five

�-helices (Fig. 3a). Two helices, �1 and �4, are on one side of

the �-sheet and are parallel to each other; helices �2 and �3

are on the other side of the �-sheet and are almost parallel to

each other. The �5 helix extends outside the protein structure

and terminates at the C-terminal end. Both the N-terminal and

C-terminal regions are closer on one side of the monomeric

structure of sLS. In addition, the N-terminal residues 1–4 form

a �-strand (�1). The overall secondary-structure elements are

arranged in the order �1-�2-�1-�3-�2-�4-�3-�5-�4-�5, as

shown in Fig. 3(a). All of the �-strands and �-helices are

interconnected by either loops or turns. The smallest turn is

that between �3 and �2 (54–57) and the longest is that

between �4 and �5 (128–136). All of these loops and turns are

conserved structurally, including the turn connecting the �4

and �5 helices (helix–turn–helix motif) in all species.

3.4. Pentameric substructure of sLS

The pentamer of sLS forming a central channel with a

diameter of about 10 A is shown in Fig. 3(b). The inner side of

the channel is mainly occupied by hydrophilic residues (Glu91,

Asn99 etc.) and is surrounded by �3 helices, forming a left-

handed twist. In addition, the five subunits interact with each

other through hydrogen-bonding and hydrophobic inter-

actions to form the assembly. Specifically, the Ile4 residues

from strand �1 form hydrogen bonds with Val51 and Trp53

which belong to the �3 strand of the other subunit. Similarly,

residues Glu91 (�3) from one subunit interact with Tyr92 (�3)

from other subunit, Ser98 (�3) interacts with Tyr58 (�2) of the

other subunit, Glu106 (�3) interacts with Ser103 (�3) and

Glu65 (�2) of the other subunit and Glu146 (�5) interacts with

Arg21 (�2) of the other subunit. There are some hydrophobic

interactions between Leu151 (�5) and Leu62 (�2) of the other

subunit: Thr143 (�5) interacts with Pro55 (which belongs to a

loop between �3 and �2) of the other subunit and Phe114 (�5)

interacts with Tyr58 (�2) of the other subunit. Thus, inter-

actions between the subunits are between �1–�3, �3–�2, �3–

�3, �5–�2 and �5–�2. The total accessible surface area (Lee &

Richards, 1971) calculated for each monomer is about

8095 A2; however, this area is reduced to 5450 A2 upon

pentamer formation, corresponding to 32.6% buried surface

area and suggesting that the pentamer is a stable complex.

In general, active lumazine synthase structures are either

observed as pentamers, dimers of pentamers or dodecamers

of pentamers, suggesting that the basic substructure is a

pentamer for all LS. However, the sequence similarity among

LS homologues with known structures is between 18% and

93% identity, suggesting that complementarity of the interface

surfaces rather than conservation of the

hydrogen-bonding pattern plays a role in

pentamer formation (Persson et al., 1999). In

addition, burial of hydrophobic residues has

also been suggested to play a role in the

formation and stabilization of pentamers in

S. cerevisiae LS (Meining et al., 2000). Based

on sequence similarity, we predict that the

burial of hydrophobic residues will also play

a role in the formation of pentamers in sLS.

3.5. Icosahedral assembly of sLS

In sLS, the 60 monomeric subunits are

assembled to form an icosahedral capsid as

shown in Fig. 3(c) which is similar to other

reported icosahedral LS structures (Ritsert

research papers

6 of 9 Kumar et al. � Lumazine synthase Acta Cryst. (2011). D67

Figure 4Stereoview showing the proposed model for binding of the substrates at the active site of sLS.

Files: d/xb5025/xb5025.3d d/xb5025/xb5025.sgml XB5025 FA IU-1113/24(3)1 1113/16(3)1 () XB5025 PROOFS D:FA:2011:67:1:0:0–0

571

572

573

574

575

576

577

578

579

580

581

582

583

584

585

586

587

588

589

590

591

592

593

594

595

596

597

598

599

600

601

602

603

604

605

606

607

608

609

610

611

612

613

614

615

616

617

618

619

620

621

622

623

624

625

626

627

628

629

630

631

632

633

634

635

636

637

638

639

640

641

642

643

644

645

646

647

648

649

650

651

652

653

654

655

656

657

658

659

660

661

662

663

664

665

666

667

668

669

670

671

672

673

674

675

676

677

678

679

680

681

682

683

684

Page 7: research papers Crystal structure analysis of icosahedral ...crdd.osdd.net/open/482/1/karthi-acta-d.pdfmixing 1 ml protein solution with 1 ml reservoir buffer, equilibrating against

et al., 1995; Persson et al., 1999; Zhang et al., 2001). Five

neighbouring subunits interact with each other to form a

pentamer unit and each pentagonal unit makes edge-to-edge

contacts with five pentamer neighbours, corresponding to the

arrangement of the faces of the pentagonal dodecahedron, in

which three corners are joined at each threefold axis and the

angle between each neighbouring pentamer is around 60�.

Such an arrangement of pentameric capsomeres indicates a

T = 1 icosahedral assembly according to icosahedral assembly

nomenclature (Caspar & Klug, 1962; Johnson & Speir, 1997).

The total diameter of the compact icosahedron is around

160 A, with the diameter of the inner core being around 80 A

and the width of the pentameric capsomere along its central

axis being around 40 A (Fig. 3d). The volume of the central

core of the icosahedral capsid corresponds to 2.90 � 105 A3.

Each monomer in the capsid is arranged in such a way that the

active sites are located towards the interior of the capsid.

To date, crystal structures of LS from B. subtilis, S. oleracea

and A. aeolicus that form icosahedral assemblies have been

reported (Ladenstein et al., 1994; Persson et al., 1999; Zhang

et al., 2001). In B. subtilis, two enzymes, namely lumazine

synthase and riboflavin synthase (RS), form a 1 MDa complex

composed of three subunits of RS and 60 subunits of LS. It has

been proposed that the tight packing of LS and RS improves

the catalytic efficiency by substrate channelling at low sub-

strate concentrations (Kis & Bacher, 1995). In addition, it was

shown that the LS catalytic activities from the native enzyme

complex of B. subtilis and the reconstituted hollow icosahedral

capsid are identical (Kis et al., 1995). It was also reported that

lumazine synthase from E. coli does not physically associate

with any other enzyme of the riboflavin pathway and that the

core of the icosahedral capsid is empty (Mortl et al., 1996).

Moreover, it was shown that LS activities are similar in both

the icosahedral and pentameric forms, suggesting that capsid

research papers

Acta Cryst. (2011). D67 Kumar et al. � Lumazine synthase 7 of 9

Figure 5Multiple sequence alignment of lumazine synthases from different species. The secondary structures are indicated on the top row for S. typhimurium.Residues that are strictly conserved are shown with a red background, residues that are well conserved within a group are indicated by red letters andresidues that are conserved between groups are boxed. This figure was generated using ESPript (Gouet et al., 1999).

Files: d/xb5025/xb5025.3d d/xb5025/xb5025.sgml XB5025 FA IU-1113/24(3)1 1113/16(3)1 () XB5025 PROOFS D:FA:2011:67:1:0:0–0

685

686

687

688

689

690

691

692

693

694

695

696

697

698

699

700

701

702

703

704

705

706

707

708

709

710

711

712

713

714

715

716

717

718

719

720

721

722

723

724

725

726

727

728

729

730

731

732

733

734

735

736

737

738

739

740

741

742

743

744

745

746

747

748

749

750

751

752

753

754

755

756

757

758

759

760

761

762

763

764

765

766

767

768

769

770

771

772

773

774

775

776

777

778

779

780

781

782

783

784

785

786

787

788

789

790

791

792

793

794

795

796

797

798

Page 8: research papers Crystal structure analysis of icosahedral ...crdd.osdd.net/open/482/1/karthi-acta-d.pdfmixing 1 ml protein solution with 1 ml reservoir buffer, equilibrating against

formation is not involved in the catalytic activity of the

enzyme (Mortl et al., 1996; Persson et al., 1999). However,

studies to dissociate the capsid formation using mild dena-

turants resulted in larger capsid formation without any LS

activity, suggesting that the quaternary structure is tightly

correlated with catalytic function (Zhang et al., 2006). Thus,

the requirement for icosahedral assembly formation for

certain species and the driving forces required for the

assembly formation of lumazine synthase have remained

unclear to date.

3.6. Substrate-binding site

In sLS, the catalytic site was located by the bound sulfate

ion which mimics the phosphate moiety of the DHBP sub-

strate (Fig. 4). The active site of sLS is formed at the interior

surface of the icosahedral interface between two subunits of

each pentamer. The active site is composed mainly of residues

from the loops connecting the �2 strand and �1 helix, the �3

strand and �2 helix and the �4 strand and �3 helix from one

subunit and the �5 strand, �4 helix and �5 helix from the other

subunit of the same pentamer.

We have predicted the residues of sLS involved in substrate

binding and catalysis by modelling the substrates ARAPD and

DHBP based on structures of LS of M. tuberculosis complexed

with inhibitors (PDB entries 2c97 and 2vi5; Morgunova et al.,

2006; Zhang et al., 2008). In sLS, the residues Phe22, Asn23,

Gly56, Ala57 and Tyr58 from one subunit and Phe114 from

the other subunit are residues that could potentially interact

with the substrate ARAPD. The sulfate which occupies the

same position as the phosphate of the substrate DHBP

revealed that residues Gly86, Thr87 and His89 from one

subunit and Arg128 from the other subunit may be involved

in binding the DHBP substrate (Fig. 4). All of the residues

involved in the active site are mostly conserved among species

(Fig. 5); moreover, no difference in the catalytic activity

between the pentamer and the icosahedral capsid could be

established, suggesting a similar catalytic mechanism in all

species.

3.7. Comparsion of sLS with other lumazine synthasestructures

The sLS monomeric structure could be superimposed onto

B. subtilis LS (PDB code 1rvv; Ritsert et al., 1995) with a root-

mean-square deviation (r.m.s.d.) of 0.93 A for 153 C� atoms,

onto A. aeolicus LS (1nqu; Zhang et al., 2003) with an r.m.s.d.

of 1.02 A for 152 C� atoms, onto S. oleracea LS (1c2y; Persson

et al., 1999) with an r.m.s.d. of 1.0 A for 150 C� atoms, onto

S. pombe LS (1kyv; Gerhardt et al., 2002) with an r.m.s.d. of

1.20 for 120 C� atoms, onto M. tuberculosis LS (2c92;

Morgunova et al., 2006) with an r.m.s.d. of 1.05 A for 138 C�

atoms, onto B. abortus LS (2f59; Klinke et al., 2007) with an

r.m.s.d. of 1.10 A for 130 C� atoms and onto C. albicans LS

(2jfb; Morgunova et al., 2007) with an r.m.s.d. of 1.13 A for 141

C� atoms, reflecting the high similarity among LS structures.

Studies of lumazine synthase structures to identify the

elements that are responsible for the formation of the icosa-

hedral assembly suggested two regions that may be involved in

icosahedral capsid formation (Mortl et al., 1996; Persson et al.,

1999). Firstly, the formation of a �-strand (�1) in the

N-terminal region which interacts with the core �-sheet of the

adjacent subunit of LS may potentially

help in formation of the icosahedral

assembly (Fig. 6). In the case of

pentamer-forming LS, these N-terminal

residues are either disordered or are

observed in a conformation which is

unlikely to form a �-strand with the

neighbouring subunit owing to the

presence of a proline residue at the

N-terminus as observed in the M. grisea

(Persson et al., 1999), S. cerevisiae

(Meining et al., 2000), M. tuberculosis

(Morgunova et al., 2005) and S. pombe

(Gerhardt et al., 2002) structures.

However, in the case of sLS a proline

(Pro11) residue was found in the

N-terminal region but it could still form

an icosahedral assembly, suggesting that

the proline residue may not play a role

in the formation of the icosahedral

assembly. Secondly, the size and orien-

tation of the loop between helices �4

and �5 play a role in -assembly forma-

tion. In the icosohedral capsid, the loop

is shorter and makes a turn which could

be compatible with the formation of the

research papers

8 of 9 Kumar et al. � Lumazine synthase Acta Cryst. (2011). D67

Figure 6Superposition of LS structures from the organisms forming icosahedral assemblies are shown ingreen, those from the organisms forming pentameric assemblies are shown in pink and that from theorganism forming a decamer (dimer of pentamers) is shown in blue. The proline residue of sLS isshown as a stick model (green). The inset shows a close-up view of the different conformations ofthe loop between the �4 and �5 helices.

Files: d/xb5025/xb5025.3d d/xb5025/xb5025.sgml XB5025 FA IU-1113/24(3)1 1113/16(3)1 () XB5025 PROOFS D:FA:2011:67:1:0:0–0

799

800

801

802

803

804

805

806

807

808

809

810

811

812

813

814

815

816

817

818

819

820

821

822

823

824

825

826

827

828

829

830

831

832

833

834

835

836

837

838

839

840

841

842

843

844

845

846

847

848

849

850

851

852

853

854

855

856

857

858

859

860

861

862

863

864

865

866

867

868

869

870

871

872

873

874

875

876

877

878

879

880

881

882

883

884

885

886

887

888

889

890

891

892

893

894

895

896

897

898

899

900

901

902

903

904

905

906

907

908

909

910

911

912

Page 9: research papers Crystal structure analysis of icosahedral ...crdd.osdd.net/open/482/1/karthi-acta-d.pdfmixing 1 ml protein solution with 1 ml reservoir buffer, equilibrating against

icosohedral capsid. However, in the pentameric form this loop

is longer and has a different orientation which prevents the

formation of the icosahedral capsid (Fig. 6). In sLS the loop is

short, similar to other icosahedral assembly-forming LS, and

thus is compatible with the formation of the icosahedral

capsid, suggesting that this loop region may play a role in the

formation of the icosahedral assembly. However, further

studies are required to identify the driving forces for the

formation of the icosahedral assembly.

We thank Ruchi Gautam for her assistance in protein

purification. We also thank Sharanjit Kaur and Purnananda

Guptasarma for the MALDI analysis and Dr Srikrishna

Subramanian for carefully reading the manuscript. PK and MS

thank the Council of Scientific and Industrial Research

(CSIR), Government of India for doctoral fellowships. This

work was supported by CSIR through the network project

NWP05.

References

Adams, P. D. et al. (2010). Acta Cryst. D66, 213–221.Bacher, A. (1991). Chemistry and Biochemistry of Flavoenzymes, Vol.

1, edited by F. Muller, pp. 215–259. Boca Raton: CRC Press.Bacher, A., Eberhardt, S. & Richter, G. (1996). In Escherichia coliand Salmonella: Cellular and Molecular Biology, 2nd ed., edited byF. C. Neidhardt, J. L. Ingraham, K. B. Low, B. Magasanik, M.Schaechter & H. E. Umbarger. Washington: American Society forMicrobiology.

Not cited in text – Bacher, A. & Ladenstein, R. (1990). Chemistry andBiochemistry of Flavoenzymes, Vol. 1, edited by F. Muller, pp. 293–316. Boca Raton: CRC Press.

Not cited in text – Bellido, D., Craig, P. O., Mozgovoj, M. V.,Gonzalez, D. D., Wigdorovitz, A., Goldbaum, F. A. & Dus Santos,M. J. (2009). Vaccine, 27, 136–145.

Not cited in text – Braden, B. C., Velikovsky, C. A., Cauerhff, A. A.,Polikarpov, I. & Goldbaum, F. A. (2000). J. Mol. Biol. 297, 1031–1036.

Bradford, M. M. (1976). Anal. Biochem. 72, 248–254.Briggs, W. R. & Huala, E. (1999). Annu. Rev. Cell Dev. Biol. 15,

33–62.Caspar, D. L. & Klug, A. (1962). Cold Spring Harb. Symp. Quant.Biol. 27, 1–24

Collaborative Computational Project, Number 4 (1994). Acta Cryst.D50, 760–763.

Emsley, P. & Cowtan, K. (2004). Acta Cryst. D60, 2126–2132.Fornasari, M. S., Laplagne, D. A., Frankel, N., Cauerhff, A. A.,

Goldbaum, F. A. & Echave, J. (2004). Mol. Biol. Evol. 21, 97–107.Gerhardt, S., Haase, I., Steinbacher, S., Kaiser, J. T., Cushman, M. &

Bacher, A. (2002). J. Mol. Biol. 318, 1317–1329.Gouet, P., Courcelle, E., Stuart, D. I. & Metoz, F. (1999).Bioinformatics, 15, 305–308.

Johnson, J. E. & Speir, J. A. (1997). J. Mol. Biol. 269, 665–675.Not cited in text – Karshikoff, A. & Ladenstein, R. (1989). Proteins,5, 248–257.

Kis, K. & Bacher, A. (1995). J. Biol. Chem. 270, 16788–16795.Kis, K., Volk, R. & Bacher, A. (1995). Biochemistry, 34, 2883–2892.

Kleywegt, G. J. & Jones, T. A. (1994). Jnt CCP4/ESF–EACBM Newsl.Protein Crystallogr. 31, 9–14.

Klinke, S., Zylberman, V., Bonomi, H. R., Haase, I., Guimaraes, B. G.,Braden, B. C., Bacher, A., Fischer, M. & Goldbaum, F. A. (2007). J.Mol. Biol. 373, 664–680.

Ladenstein, R., Ritsert, K., Huber, R., Richter, G. & Bacher, A.(1994). Eur. J. Biochem. 223, 1007–1017.

Laemmli, U. K. (1970). Nature (London), 227, 680–685.Laskowski, R. A., Moss, D. S. & Thornton, J. M. (1993). J. Mol. Biol.231, 1049–1067.

Lee, B. & Richards, F. M. (1971). J. Mol. Biol. 55, 379–400.Matthews, B. W. (1968). J. Mol. Biol. 33, 491–497.McCoy, A. J., Grosse-Kunstleve, R. W., Storoni, L. C. & Read, R. J.

(2005). Acta Cryst. D61, 458–464.Meighen, E. A. (1991). Microbiol. Rev. 55, 123–142.Meighen, E. A. (1993). FASEB J. 7, 1016–1022.Meining, W., Mortl, S., Fischer, M., Cushman, M., Bacher, A. &

Ladenstein, R. (2000). J. Mol. Biol. 299, 181–197.Morgunova, E., Illarionov, B., Sambaiah, T., Haase, I., Bacher, A.,

Cushman, M., Fischer, M. & Ladenstein, R. (2006). FEBS J. 273,4790–4804.

Morgunova, E., Meining, W., Illarionov, B., Haase, I., Jin, G. &Bacher, A. (2005). Biochemistry, 44, 2746–2758.

Morgunova, E., Saller, S., Haase, I., Cushman, M., Bacher, A.,Fischer, M. & Ladenstein, R. (2007). J. Biol. Chem. 282, 17231–17241.

Mortl, S., Fischer, M., Richter, G., Tack, J., Weinkauf, S. & Bacher, A.(1996). J. Biol. Chem. 271, 33201–33207.

Murshudov, G. N., Vagin, A. A. & Dodson, E. J. (1997). Acta Cryst.D53, 240–255.

O’Kane, D. J. & Prasher, D. C. (1992). Mol. Microbiol. 6, 443–449.Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 276, 307–326.Persson, K., Schneider, G., Jordan, D. B., Viitanen, P. V. & Sandalova,

T. (1999). Protein Sci. 8, 2355–2365.Plaut, G. W., Beach, R. L. & Aogaichi, T. (1970). Biochemistry, 9,

771–785.Plaut, G. W. & Harvey, R. A. (1971). Methods Enzymol. 18B, 515–539.Ramachandran, G. N. & Sasisekharan, V. (1968). Adv. Protein Chem.23, 283–438.

Ritsert, K., Huber, R., Turk, D., Ladenstein, R., Schmidt-Base, K. &Bacher, A. (1995). J. Mol. Biol. 253, 151–167.

Salomon, M., Eisenreich, W., Durr, H., Schleicher, E., Knieb, E. &Massey, V. (2001). Proc. Natl Acad. Sci. USA, 98, 12357–12361.

Thompson, C. L. & Sancar, A. (2002). Oncogene, 21, 9043–9056.Volk, R. & Bacher, A. (1991). J. Biol. Chem. 266, 20610–20618.Not cited in text – Yang, Z., Bahar, I. & Widom, M. (2009). Biophys.J. 96, 4438–4448.

Young, D. W. (1986). Nat. Prod. Rep. 3, 395–419.Zhang, X., Konarev, P. V., Petoukhov, M. V., Svergun, D. I., Xing, L.,

Cheng, R. H., Haase, I., Fischer, M., Bacher, A., Ladenstein, R. &Meining, W. (2006). J. Mol. Biol. 362, 753–770.

Zhang, X., Meining, W., Cushman, M., Haase, I., Fischer, M., Bacher,A. & Ladenstein, R. (2003). J. Mol. Biol. 328, 167–182.

Zhang, X., Meining, W., Fischer, M., Bacher, A. & Ladenstein, R.(2001). J. Mol. Biol. 306, 1099–1114.

Zhang, Y., Illarionov, B., Morgunova, E., Jin, G., Bacher, A., Fischer,M., Ladenstein, R. & Cushman, M. (2008). J. Org. Chem. 73, 2715–2724.

Zylberman, V., Craig, P. O., Klinke, S., Braden, B. C., Cauerhff, A. &Goldbaum, F. A. (2004). J. Biol. Chem. 279, 8093–8101.

research papers

Acta Cryst. (2011). D67 Kumar et al. � Lumazine synthase 9 of 9

Files: d/xb5025/xb5025.3d d/xb5025/xb5025.sgml XB5025 FA IU-1113/24(3)1 1113/16(3)1 () XB5025 PROOFS D:FA:2011:67:1:0:0–0

913

914

915

916

917

918

919

920

921

922

923

924

925

926

927

928

929

930

931

932

933

934

935

936

937

938

939

940

941

942

943

944

945

946

947

948

949

950

951

952

953

954

955

956

957

958

959

960

961

962

963

964

965

966

967

968

969

970

971

972

973

974

975

976

977

978

979

980

981

982

983

984

985

986

987

988

989

990

991

992

993

994

995

996

997

998

999

1000

1001

1002

1003

1004

1005

1006

1007

1008

1009

1010

1011

1012

1013

1014

1015

1016

1017

1018

1019

1020

1021

1022

1023

1024

1025

1026